Evidence map›Paper›PMID 40739141›Full record

ArticleNature communications2025

Continuous structure modification of metal-organic framework glasses via halide salts.

Fengming Cao, Søren S Sørensen, Anders K R Christensen, Samraj Mollick, Xuan Ge, Daming Sun, Anders B Nielsen, Niels Chr Nielsen, Nina Lock, Ronghui Lu and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Luminescent Chiral Molecular Glasses by Melt-Quenching Enantiopure BINAP.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Fengming Cao *Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0003-0761-5019
Søren S Sørensen *Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark. soe@bio.aau.dk.ORCID http://orcid.org/0000-0003-2230-7823
Anders K R ChristensenDepartment of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
Samraj MollickDepartment of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
Xuan GeDepartment of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
Daming SunDepartment of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
Anders B NielsenDepartment of Chemistry, Aarhus University, Aarhus, Denmark.
Niels Chr NielsenDepartment of Chemistry, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-2978-4366
Nina LockInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark.
Ronghui LuInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark.
Rebekka KlemmtInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0009-0006-4912-2043
Peter K KristensenDepartment of Materials and Production, Aalborg University, Aalborg, Denmark.
Lars R JensenDepartment of Materials and Production, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0003-1617-0306
Francesco DallariDepartment of Physics and Astronomy 'Galileo Galilei', University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0003-0171-8084
Jacopo BaglioniDepartment of Physics and Astronomy 'Galileo Galilei', University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0003-0322-0941
Giulio MonacoDepartment of Physics and Astronomy 'Galileo Galilei', University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0003-2497-6422
Martin A KarlsenDeutsches-Elektronen Synchrotron (DESY), Hamburg, Germany.ORCID http://orcid.org/0000-0003-1262-8965
Volodymyr BaranDeutsches-Elektronen Synchrotron (DESY), Hamburg, Germany.ORCID http://orcid.org/0000-0003-2379-3632
Morten M SmedskjaerDepartment of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark. mos@bio.aau.dk.ORCID http://orcid.org/0000-0003-0476-2021

Funding

Carlsbergfondet (Carlsberg Foundation) CF20-0364Carlsbergfondet (Carlsberg Foundation) CF21-0371China Scholarship Council (CSC) 202206890034Danish e-Infrastructure Cooperation (DeIC) DeiC-AAU-N5-000006Deutsches Elektronen-Synchrotron (DESY) I-20230857 ECMinistry of Science, Innovation and Higher Education | Styrelsen for Forskning og Innovation (Danish Agency for Science, Technology and Innovation) 8144-00002Novo Nordisk Fonden (Novo Nordisk Foundation) NNF220C0075797Novo Nordisk Fonden (Novo Nordisk Foundation) NNF22OC0076002
6 · The paper itself

Abstract

Melting and glass formation of metal-organic frameworks (MOFs) allow them to be processed into bulk materials. However, two major challenges remain: only a small fraction of MOF crystals undergo melting and glass-formation, and no well-established strategies exist for tuning MOF glass structures and properties. Here, we address both challenges through co-melting of zeolitic imidazole frameworks (ZIFs), a subset of MOFs, with heterocycle-based halide salts. The salt acts as a chemical "modifier", akin to the role of alkali modifiers in traditional silicate glasses, e.g., allowing the melting of ZIF-8 that otherwise decomposes prior to melting. Through experimental and computational analyses, we show that the salts depolymerize the ZIFs, enabling continuous tuning of the fraction of bridging to non-bridging imidazolate linkers and, thereby, the thermal and mechanical properties. The proposed strategy enables diversification of MOF glass chemistry, tunable structures and properties, and ultimately an increased number of glass-forming MOFs with improved functionalities.

Identifiers

PMID40739141
PMCPMC12311036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.